Scinovex
article Open Access

Phytomolecules: A potential bioenhancer for pharmaceutical drugs

Journal of Pharmacognosy and Phytochemistry · 2022 · Vol. 11(2) · pp. 120–125

Abstract

Phyto-bioenhancer is an agent of herbal origin, which is capable of enhancing bio-availability and bio-efficacy of a particular drug or nutrient with which it is combined, without any typical pharmacological activity of its own at the dose used. These phyto-bioenhancers reduce the dose, decrease the treatment duration and increase the recovery rate. They also reduce the drug resistance or related adverse reactions which have economical implications in human, livestock and pet medicine. The main mechanisms involved for these phyto-bioenhancers are related to drug absorption i.e. effect on solubility, drug efflux and transport proteins, increased permeability in gastrointestinal system and drug metabolism i.e. inhibition/induction of drug metabolizing enzymes and thermogenic effect. The concept of bioenhancer is to achieve better therapeutic response in appropriate dose using phytomolecules like ginger, caraway, aloe, quercetin, glycyrrhizin piperine, curcumin etc. The use of phyto-bioenhancer is the most reliable means for bioavailability enhancement because these are safe, non-toxic, economical, easily procured, non-addictive, pharmacologically inert and non-allergenic in nature etc. Phyto-bioenhancers are used for various categories of drug like neutraceuticals, antibiotics, antitubercular, anticancer and cardiovascular for immediate effects. Therefore, there is a need to carry out extensive research on these phyto-bioenhancer so that they could be utilized in the marketed formulation in future prospective. Researchers must solve some issues of drug toxicity to deliver a safe and effective dose of drugs to attain desired pharmacological response.

Natural Antidiabetic Agents StudiesNigella sativa pharmacological applicationsDiverse Scientific Research StudiesPiperineDrugBioavailabilityPharmacologyCurcuminMedicineGlycyrrhizinTraditional medicine
Citations
3
FWCI
0.28
field-weighted impact
References
33
Percentile
57%
vs. same field & year
Citations per year
References
Piperine, a Major Constituent of Black Pepper, Inhibits Human P-glycoprotein and CYP3A4
Journal of Pharmacology and Experimental Therapeutics · 2002 · 524 citations
A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Journal of the American Medical Association · 1909 · 7,903 citations
Natural Bioenhancers: An overview
Journal of Pharmacognosy and Phytochemistry · 2013 · 55 citations
Journal of Pharmacognosy and Phytochemistry
Journal of Pharmacognosy and Phytochemistry · 2018 · 4,036 citations
Related articles
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.